Banco Santander S.A. Acquires 4,428 Shares of Sanofi (NASDAQ:SNY)

Banco Santander S.A. increased its holdings in Sanofi (NASDAQ:SNY) by 11.6% during the 4th quarter, HoldingsChannel.com reports. The firm owned 42,494 shares of the company’s stock after purchasing an additional 4,428 shares during the period. Banco Santander S.A.’s holdings in Sanofi were worth $2,049,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Charles Schwab Investment Management Inc. boosted its position in Sanofi by 31.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 139,505 shares of the company’s stock valued at $8,040,000 after acquiring an additional 33,105 shares during the last quarter. Arkadios Wealth Advisors boosted its position in Sanofi by 19.0% during the fourth quarter. Arkadios Wealth Advisors now owns 4,709 shares of the company’s stock valued at $227,000 after acquiring an additional 751 shares during the last quarter. Geode Capital Management LLC boosted its position in Sanofi by 7.1% during the third quarter. Geode Capital Management LLC now owns 254,738 shares of the company’s stock valued at $14,681,000 after acquiring an additional 16,780 shares during the last quarter. JPMorgan Chase & Co. boosted its position in Sanofi by 20.9% during the third quarter. JPMorgan Chase & Co. now owns 2,310,809 shares of the company’s stock valued at $133,172,000 after acquiring an additional 399,301 shares during the last quarter. Finally, Kentucky Trust Co bought a new stake in Sanofi during the fourth quarter valued at $436,000. Institutional investors own 14.04% of the company’s stock.

Sanofi Price Performance

Shares of NASDAQ SNY opened at $59.25 on Monday. The company has a current ratio of 1.46, a quick ratio of 1.14 and a debt-to-equity ratio of 0.15. Sanofi has a 1-year low of $45.22 and a 1-year high of $59.72. The firm has a market capitalization of $150.37 billion, a P/E ratio of 23.80, a P/E/G ratio of 1.01 and a beta of 0.58. The firm’s 50-day moving average price is $52.65 and its 200-day moving average price is $52.73.

Sanofi (NASDAQ:SNY) last posted its earnings results on Thursday, January 30th. The company reported $0.70 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. Equities research analysts anticipate that Sanofi will post 4.36 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have commented on SNY shares. Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday, January 30th. Sanford C. Bernstein upgraded shares of Sanofi to a “strong-buy” rating in a report on Thursday, January 30th. Finally, StockNews.com lowered shares of Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Two research analysts have rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Buy” and an average price target of $60.00.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.